Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Rhinol Allergy. 2013 Jan;27(1):34-8. doi: 10.2500/ajra.2013.27.3831.

Antibody deficiency in chronic rhinosinusitis: epidemiology and burden of illness.

Author information

1
Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

Abstract

BACKGROUND:

A subset of patients with chronic rhinosinusitis (CRS) has refractory disease. The risk factors for refractory CRS include atopy, a disrupted mucociliary transport system, medical conditions affecting the sinonasal tract mucosa, and immunodeficiency.

METHODS:

We review four primary immunodeficiencies reported in individuals with CRS: common variable immune deficiency (CVID), selective IgA deficiency, IgG subclass deficiency, and specific antibody deficiency. We also review treatment options for individuals with both CRS and a concomitant immune defect.

RESULTS:

There is a high prevalence of CRS in individuals with CVID and selective IgA deficiency. While many reports describe IgG subclass deficiency in individuals with CRS, the clinical relevance of this is unclear. Specific antibody deficiency may play a more significant role in the pathogenesis of refractory CRS.

CONCLUSION:

Screening for a primary immunodeficiency should be part of the diagnostic workup of refractory CRS, as its identification may allow for more effective long-term therapeutic options.

PMID:
23406598
PMCID:
PMC3903100
DOI:
10.2500/ajra.2013.27.3831
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Ingenta plc Icon for PubMed Central
    Loading ...
    Support Center